down arrow

Devonian Health Group, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA2518341078
CAD
0.22
0.00 (0.00%)

Dec 04

TSX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Medexus Pharmaceuticals, Inc.
Devonian Health Group, Inc.
Theratechnologies, Inc.
Alpha Cognition, Inc.
Arch Biopartners, Inc.
Helix BioPharma Corp.
Satellos Bioscience, Inc.
Aptose Biosciences, Inc.
Mindset Pharma, Inc.
Sirona Biochem Corp.
Antibe Therapeutics, Inc.
Why is Devonian Health Group, Inc. ?
1
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -2.22%, its profits have risen by 108.8% ; the PEG ratio of the company is 0.3
2
Underperformed the market in the last 1 year
  • Even though the market (S&P/TSX 60) has generated returns of 18.73% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -2.22% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Devonian Health Group, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Devonian Health Group, Inc.
-2.22%
0.32
175.95%
S&P/TSX 60
19.1%
1.23
15.27%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
67.72%
EBIT Growth (5y)
16.37%
EBIT to Interest (avg)
-2.34
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.10
Sales to Capital Employed (avg)
0.97
Tax Ratio
10.61%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.64%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
37
Industry P/E
Price to Book Value
4.20
EV to EBIT
27.34
EV to EBITDA
18.56
EV to Capital Employed
-27.34
EV to Sales
0.87
PEG Ratio
0.34
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
3.19%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

24What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CAD 8.44 MM

NET SALES(HY)

At CAD 16.19 MM has Grown at 107.94%

INVENTORY TURNOVER RATIO(HY)

Highest at 166.26%

PRE-TAX PROFIT(Q)

At CAD 0.04 MM has Grown at 109.54%

RAW MATERIAL COST(Y)

Fallen by -31.46% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -108.94 %

NET PROFIT(Q)

At CAD 0.04 MM has Grown at 105.53%

-5What is not working for the Company
ROCE(HY)

Lowest at -41.09%

EPS(Q)

Lowest at CAD -0.03

Here's what is working for Devonian Health Group, Inc.
Net Sales
At CAD 16.19 MM has Grown at 107.94%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (CAD MM)

Operating Cash Flow
Highest at CAD 8.44 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CAD MM)

Pre-Tax Profit
At CAD 0.04 MM has Grown at 109.54%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CAD MM)

Inventory Turnover Ratio
Highest at 166.26% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Net Profit
At CAD 0.04 MM has Grown at 105.53%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CAD MM)

Debt-Equity Ratio
Lowest at -108.94 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -31.46% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Devonian Health Group, Inc.
EPS
Lowest at CAD -0.03
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (CAD)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."